Hinge Health, 10-year-old company offers digital solutions to treat chronic muscloskeletal conditions (MSK), filed to go publicSee rankings-.
Although hinges have not announced the number of stocks, or the value, the specialist IPPO in the Capital Renaissance estimate the company $ 500 million in a gift.
Hinge’s Hinge’s Hinge in 2024 is $ 390 million, increase 33% of the previous year, when the Net Narrow Loss up $ 11.9 million of 2023, according to the IPO prospectus.
The purpose of the purpose of reducing MSK’s pain through the use of sensors that can be worn and the Vision Vision Technology is monitored away by the clinical treatment team team, physician and healthcare and healthy health coach.
Last huns cost $ 6.2 billion In October 2021 while raising $ 400 series of Tiger Global and Coatue Management. The company has produced a total of $ 828 million in the business capital, according to Pitchbook data.
The largest companies are the largest shareholders are the biggest partner, which holds 19% of all stocks, and atomico, which has 15% of all stocks. Other business capital that have about 8% hinge stock includes 11.2 Capital, Global Coanter, and the Cancer Business Partner, according to filing. Co-founder Daniel Persz and Gabriel Mecklenburg own 18.9% and 8.2%.
The main competitor is hinge as a sword health, which is $ 3 billion years ago. Bento Virgílio, CEO and sword sword, tells the techcrunch Last year if the company grows like an expected and macroeconomic environment, can also devote public listings in 2025.
Another hinge-competitor includes maia health software, health, and viries health.
